GX Conscious Companies ETF KRMA

$40.35 -0.15 (-0.37%)

Valuation

Market cap
—
Revenue TTM
—
Net income TTM
—
P/E (trailing)
—
P/E (forward)
—
Profit margin
—
Debt to equity
—

Trading

Volume
4,052
Avg volume
—
Day's range
$40.29 – $40.53
Shares out
—
Stochastic %K
—
Beta
—
Analysts
—
Price target
—

Price

Company profile

The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to companies that Morningstar, Inc. (the “index provider”) determines exhibit strong capital allocation practices, as measured by the index Provider’s proprietary capital allocation rating framework.

Phone
+1 8884938631

Latest news

No headlines yet.

Stocktwits

BillionerOfKing Feb 25, 3:33 AM
$KRMA Current Stock Price: $43.52
0 replies
FrancesHendricks796 Feb 21, 7:09 AM
$KRMA Global X Conscious Companies ETF emphasizes ESG leaders. Performance depends on sector exclusions. Volatility is moderate.
0 replies
AlphaTuna Dec 31, 12:00 AM
Lowest Volume Rated ETFs Per 12/30/2026’s Close: 1 – $KCSH 2 – $NJNK 3 – $GLDB 4 – $JHCP 5 – $PSMO 6 – $PLDR 7 – $KRMA 8 – $NUGO 9 – $CPSD 10 – $GBXA https://optimizedvalue.xyz/daily-voltech-stock-etf-volume-technical-ratings-12-30-2026/
0 replies
AlphaTuna Oct 25, 4:13 PM
Highest Volume Rated ETFs Per 10/24/2025’s Close: 1 – $XIDV 2 – $XUDV 3 – $SLNZ 4 – $KRMA 5 – $PQOC 6 – $NJNK 7 – $USNZ 8 – $FFLV 9 – $GUMI 10 – $EKG https://optimizedvalue.xyz/daily-voltech-stock-etf-volume-technical-ratings-10-24-2025/
0 replies
Thunder000 Oct 7, 4:44 PM
$SPRB $ZNB $KRMA keep this under your radar $NCNA Catalysts ✅ Compliance with all Nasdaq Continued Listing Criteria Strong Cash Runway into 2029.✅ Recent RS sub 2M floater with tight shares structure right now ✅ Data 📊 this week ✅ Trading below cash and potential multi Bullion MC in the cancer market ✅ Early NUC-7738 results: 27 patients across multiple cancers. The drug lasted in the body long enough for weekly dosing. Safety was strong. No life-threatening side effects, and only occasional serious fatigue or anemia. Even in heavily pre-treated patients, doctors saw tumor shrinkage: 14–46% reductions in individual cases, and a 41% overall disease control rate. For a first-in-human study, those are promising signals.✅ DATA coming soon ✅
0 replies
AlphaTuna Sep 25, 11:32 PM
Highest Volume Rated ETFs Per 9/25/2025’s Close: 1 – $PQAP 2 – $SQMX 3 – $EFFE 4 – $NMAR 5 – $JIG 6 – $KRMA 7 – $NOVP 8 – $PATN 9 – $JIVE 10 – $EQL https://optimizedvalue.xyz/daily-voltech-stock-etf-volume-technical-ratings-9-25-2025/
0 replies
AlphaTuna Sep 9, 10:26 PM
Highest Volume Rated ETFs Per 9/9/2024’s Close: 1 – $IQHI 2 – $QSWN 3 – $KRMA 4 – $SIO 5 – $OVLH 6 – $IWLG 7 – $IQSM 8 – $ITAN 9 – $OVT 10 – $IQSU https://optimizedvalue.xyz/daily-voltech-stock-etf-volume-technical-ratings-9-9-2024/
0 replies
StockInvest_us Feb 8, 11:35 AM
Signal alert: $KRMA - PivotPoint bottom https://stockinvest.us/l/QUvZ2vbXZi
0 replies